CORESTEMCHEMON Inc. (KOSDAQ:166480)
South Korea · Delayed Price · Currency is KRW 2,125.00
+55.00 (2.66%)
At close: Sep 23, 2026
CORESTEMCHEMON Market Cap
CORESTEMCHEMON has a market cap or net worth of 94.27 billion as of September 25, 2026. Its market cap has increased by 112.62% in one year.
Market Cap
94.27B
Enterprise Value
127.48B
Revenue
18.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,125.00
ChartMarket Cap Chart
Since June 26, 2015, CORESTEMCHEMON's market cap has decreased from 653.85B to 94.27B, a decrease of -85.58%. That is a compound annual growth rate of -15.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 94.27B | 14.99% |
| Dec 30, 2025 | 81.98B | -13.27% |
| Dec 30, 2024 | 94.52B | -34.79% |
| Dec 28, 2023 | 144.95B | -43.25% |
| Dec 29, 2022 | 255.40B | -13.00% |
| Dec 30, 2021 | 293.58B | -19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Y-Biologics | 128.16B |
| ViGenCell | 117.26B |
| Prestige Biologics | 106.05B |
| Cell Biotech | 102.11B |
| AriBioLab | 98.47B |
| Choong Ang Vaccine Laboratory | 84.70B |
| EyeGene | 84.30B |
| BIO-FD&C | 79.74B |